InvestorsHub Logo
Followers 33
Posts 3081
Boards Moderated 0
Alias Born 02/28/2017

Re: None

Friday, 04/28/2017 11:30:05 AM

Friday, April 28, 2017 11:30:05 AM

Post# of 106839
FDA & Volume IMO of course:

1) Volume. Who the F*&K cares if it's low. That also means NOBODY is SELLING!!!! DUH!! So, longs are smart as anyone that would sell now PRIOR to what almost every medical related company dreams about is about to be released by THIS company. Which leads to:

2) FDA - I read an article (and believe posted it on here) about just HOW important Phase III of trials are in making or breaking a company. They are HUGE, most expensive and upon approval, usually will propel anything well into the dollars. We may actually have better than that per RMAT as this would save company possibly millions of dollars from being able to catapult past the Phase III stage based on the FDA currently evaluating the effectiveness of MyoCell right now. We are literally at the CUSP of WORLDWIDE exposure. Think about it. Muscle cells being taken from Leg area and being able to repair an injured HEART!! People do realize we need this to actually be healthy and stay ALIVE right? We are talking EARTH shattering process here!

KNOW WHAT YOU OWN!!!!!!!!!!!!

Go USRM$$$$$